ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Letter to the Editor

Epidermolysis Bullosa Acquisita Associated with Psoriasis

doi: 10.2340/00015555-0832

Abstract:

Abstract is missing (Letter)

Authors:

Rieko Kabashima, Ryosuke Hino, Toshinori Bito, Kenji Kabashima, Motonobu Nakamura, Bungo Ohyama, Takashi Hashimoto, Yoshiki Tokura

References

  • Gammon WR, Briggaman RA, Wheeler CE Jr. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol 1982; 7: 382–387.
  • Briggaman RA, Gammon WR, Woodley DT. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol 1985; 85: 79s–84s.
  • Hoshina D, Sawamura D, Nomura T, Tanimura S, Abe M, Onozuka T, et al. Epidermolysis bullosa acquisita associated with psoriasis vulgaris. Clin Exp Dermatol 2007; 32: 516–518.
  • Endo Y, Tamura A, Ishikawa O, Miyachi Y, Hashimoto T. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita. Br J Dermatol 1997; 137: 783–786.
  • Kirtschig G, Chow ET, Venning VA, Wojnarowska FT. Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. Br J Dermatol 1996; 135: 738–745.
  • Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993; 91: 1608–1615.
  • Woodley DT, Briggaman RA, O’Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984; 310: 1007–1013.
  • Tsuji T, Ohyama B, Yasumoto S, Hashimoto T. Statistical investigation of 73 cases of anti-p200 pemphigoid from 1996 to 2007. Jpn J Dermatol 2008; 118: 797.
  • Veldman C, Nagel A, Hertl M. Type I regulatory T cells in autoimmunity and inflammatory diseases. Int Arch Allergy Immunol 2006; 140: 174–183.
  • McGinness JL, Bivens MM, Greer KE, Patterson JW, Saulsbury FT. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 2006; 55: 143–148.
  • Chen L, Peterson JD, Zheng WY, Lin SX, Chan LS. Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells. Clin Exp Immunol 2006; 145: 322–331.
  • Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp Dermatol 2007; 16: 520–531.
  • Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009; 129: 79–88.
  • Fujimura T, Okuyama R, Ito Y, Aiba S. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides. Br J Dermatol 2008; 158: 1256–1263.
  • Wang H, Peters T, Sindrilaru A, Kess D, Oreshkova T, Yu XZ, et al. TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J Clin Invest 2008; 118: 2629–2639.
  • Related articles

    There are no related articles.


    Share with your friends





    Actions


    Abstract

    Full text

    PDF

    Supplementary


    There is no supplementary for this article.

    Print information


    Volume 90, Issue 3

    DOI: 10.2340/00015555-0832

    Pages: 314-316

    View at PubMed